Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study
Diabetes, Obesity and Metabolism, 08/08/2012
Hong ES et al. – Compared to a 25% increase in insulin dose, adding sitagliptin to an insulin–based regimen was more effective at lowering haemoglobin A1c (HbA1c) and associated with less hypoglycaemia and weight gain over 24 weeks.



